本页面由Tiger Trade Technology Pte. Ltd.提供服务

Purple Biotech Ltd.

4.24
+0.15003.67%
成交量:5,955.00
成交额:2.41万
市值:382.89万
市盈率:-0.08
高:4.30
开:3.94
低:3.91
收:4.09
52周最高:30.50
52周最低:3.70
股本:90.30万
流通股本:83.58万
量比:0.57
换手率:0.71%
股息:- -
股息率:- -
每股收益(TTM):-54.9640
每股收益(LYR):-54.9640
净资产收益率:-124.46%
总资产收益率:-15.97%
市净率:0.39
市盈率(LYR):-0.08

数据加载中...

2025/08/30

SEC问询函

Form CORRESP - Correspondence
2025/08/30

SEC问询函

Form CORRESP - Correspondence
2025/08/29

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/03/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/27

SEC问询函

Form CORRESP - Correspondence
2024/07/22

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

SEC问询函

Form CORRESP - Correspondence
2023/11/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/05/18

SEC问询函

Form CORRESP - Correspondence
2023/04/03

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]